From the Departments of Cardiology and Medicine (Genetics) of
Children's Hospital, Harvard Medical School, Boston, Mass (P.D., M.R.V.,
D.W., A.H.B.); the Division of Pediatric Cardiology, Kosair-Children's
Hospital, University of Louisville (Ky) School of Medicine (J.V.); and the
Department of Cardiology at Beth Israel/Deaconess Medical Center, Harvard
Medical School, Boston, Mass (V.K.).
Correspondence to Alan H. Beggs, PhD, Genetics Division, Children's Hospital, 300 Longwood Ave, Boston, MA 02115. E-mail beggs{at}rascal.med.harvard.edu
Methods and ResultsWe screened 84 unrelated patients with
Romano-Ward and 4 with JLN for possible mutations in
KCNE1. We identified one homozygous mutation in a JLN
patient that results in the nonconservative substitution of Asn for Asp
at amino acid 76. The patient is congenitally deaf-mute, with recurrent
syncopal events and a greatly prolonged QTc interval. The
proband's mother and half-sister are both heterozygous for this
mutation. Remarkably, both these family members have prolonged
QTc intervals and would have been classified as Romano-Ward
patients if not for the proband's diagnosis of JLN. This mutation was
not identified in more than 100 control individuals.
ConclusionsThese data provide strong evidence that
KCNE1 mutations represent a fifth LQTS locus
(LQT5). Further functional analysis, as well as the
identification of more LQTS patients with KCNE1
mutations, will be important to confirm the role of IsK
in LQTS.
IsK, an apparent potassium channel regulatory subunit
encoded by the KCNE1 gene on chromosome 21, has recently
been shown to coassemble with both KVLQT1, to
produce the slowly activating cardiac delayed rectifier
K+ current,
IKs,11 12 and HERG,
to regulate the rapidly activating cardiac delayed rectifier
K+ current,
IKr.13 This
relationship makes KCNE1 an attractive candidate gene for
LQTS, because mutations of both KVLQT1 and HERG
are known to cause LQTS.4 5 8 9 Originally cloned
from rat kidney, the human KCNE1 gene encodes a
129-amino-acid protein with a single putative transmembrane
domain.14 Thus far, IsK has no
sequence homology with other cloned channel subunits. Like
KVLQT1, IsK is expressed in many
tissues, including heart and inner
ear.8 11 15
A recent study reported a knockout mouse strain with a disruption of
the endogenous Kcne1 coding
sequence and absence of IsK
protein.15 Although heterozygous mice appear
normal, homozygous null mutant mice are deaf and exhibit classic
shaker/waltzer behavior. Both IsK knockout mice and JLN
patients appear to have similar developmental defects involving the
strial marginal cells of the cochlea capsule, resulting in deficient
endolymph production and congenital
deafness.16 17 These findings support the idea
that mutations in IsK may be responsible for JLN
syndrome. To test this hypothesis, 84 Romano-Ward and 4 JLN patients
were examined for possible mutations of KCNE1.
Clinical History of Family LQTS086
There was a positive family history of syncope, seizures, and partial
hearing loss of unclear cause (left ear) in her 33-year-old mother. The
proband's mother and one 3-year-old maternal half sister also have
prolonged QTc values of 0.48 and 0.47 second,
respectively. Paternal history is unknown and unavailable.
She continued on propranolol 2 mg ·
kg-1 · d-1 without
symptoms until 31/2 years later, when she presented with
another syncopal episode after exertion. Her ECG showed a prolonged
QTc of 0.68 second, with abnormal T-wave
morphology and a sinus rate of 64 bpm (Fig 1
DNA Collection and KCNE1 Mutation Analysis
Single-strand conformational polymorphism (SSCP) analysis,
band elution, and DNA sequencing were performed essentially as
described.21 Products were also
analyzed on two types of 0.5X MDE gels (FMC Bioproducts),
with and without 5% glycerol, run at room temperature at 8 W for 12 to
14 hours.
To confirm the presence of the D76N mutation, a restriction digest
assay was designed using primers 9F (5'-CTCTACGTCCTCATGGTACTG-3')
and 10R (5'-CGATGTAGACGTTGAATGAGT-3'). These primers amplify a 115-bp
product containing the mutated site. Primer 10R is mismatched at
nucleotide 257, producing a T instead of a wild-type C
three bases downstream from the mutation. This mismatch produces a
HinfI restriction site (GACTC) in the wild-type
KCNE1 gene at position 254. The D76N mutation (G254A)
abolishes this restriction site. Wild-type PCR products are cleaved
by HinfI at position 184 and at 254 to give a predominant
product of 71 bp, whereas aberrant products containing the D76N
mutation will be cleaved only at position 184, generating a 91-bp
product. Genomic DNA samples were amplified with primers 9F and 10R
as described21 at an annealing temperature of
58°C. A 5-µL volume containing 3 U HinfI, 3x BSA, and
3x restriction enzyme buffer 2 (New England Biolabs) was added to each
10-µL reaction and incubated at 37°C for 3 hours. PCR products
were separated on DNA sequencing gels and visualized with
autoradiography.21
Direct sequencing of the KCNE1 gene was performed on PCR
products of primer pairs 5F/6R and 3F/8R on an ABI 377 DNA
sequencer after purification with Wizard PCR preparation kits
(Promega).
A novel anomalous conformer was identified in one DNA sample
(LQTS086001) from the panel of LQTS patients (Fig 2B
Because the SSCP shift was subtle and difficult to appreciate on gels
containing the normal control PCR products, a PCR restriction
digest assay was designed to allow unambiguous identification of the
mutation. The D76N mutation was not detected in DNA samples from 104
North American control individuals with no clinical signs of LQTS (Fig 2D
Because the sensitivity of SSCP analysis is well below 100%,
we amplified by PCR and directly sequenced the KCNE1 genes
of all JLN probands to look for additional mutations that might have
been missed in the initial screen. The D76N mutation was readily
identified in both the homozygous patient and her heterozygous mother
and half sister. None of the other three unrelated JLN patients had any
identifiable mutations in their KCNE1 genes.
A previous study did not find evidence for involvement of
IsK in JLN syndrome in four autosomal recessive JLN
families,20 and subsequently, these workers did
identify a frame shift mutation in the carboxyl terminus of
KVLQT1 for two of their four JLN
families.8 However, linkage data for both
KCNE1 and KVLQT1 were inconclusive in the two
remaining families. Although our initial screen failed to detect any
aberrant conformers, a slight change in the location of primer 4R (eg,
8R) resulted in increased sensitivity for the G-to-A transition at
nucleotide 254, leading to our identification of this
mutation. This illustrates how the sensitivity of SSCP analysis
can be altered in unpredictable ways by apparently subtle changes to
the assay conditions. To date, we have found a homozygous
KVLQT1 mutation in one of the remaining three JLN families
(unpublished data, 1997), but the apparent absence of mutations in the
other two suggests the possibility of additional genetic
heterogeneity in this disorder.
There have been numerous previous studies of IsK
structure and function; however, many of these are difficult to
interpret because they were performed before the appreciation that
IsK is probably a regulatory subunit and not a primary
(alpha) channel subunit.11 12 13 Nevertheless,
studies performed in Xenopus oocytes recorded currents
that result from the coassembly of IsK and an
endogenous KVLQT1-like peptide and
probably reflect true functions of IsK. Fortuitously,
the rat equivalent of the D76N mutation reported here (D77N, since the
rat IsK gene includes one additional residue at
position 30) has been previously created and functionally studied in
Xenopus oocytes.25 26 Rat D77N
IsK proteins were expressed and incorporated
efficiently in the plasma membrane, yet these peptides exhibited a
drastic reduction in channel activity resulting in virtually
undetectable potassium currents.25 Coinjection of
equal amounts of D77N and wild-type mRNAs resulted in only a small
fraction of the current seen with wild-type protein alone, suggesting
that incorporation of a single mutant IsK subunit was
sufficient to disrupt channel function and possibly explaining the
dominant phenotype seen in family
LQTS086.26 Functional studies of D76N mutant
human IsK coexpressed with human
KVLQT1 will be important to determine the
molecular mechanism of this relationship as well as to prove that human
IsK-D76N has a pathological effect on
IKs currents. Identification of
additional KCNE1 mutations in LQTS patients will also
confirm this relationship and provide new insights into the structure
and function of IsK.
In the absence of information on the proband, the mother and half
sister of family LQTS086 would probably have been given a diagnosis of
Romano-Ward syndrome. Therefore, as is the case for KVLQT1,
mutations of IsK should be looked for in patients with
either the Romano-Ward or the JLN forms of LQTS. We suggest that the
KCNE1 gene, which encodes the IsK protein,
be designated as a fifth LQTS locus, LQT5.
Received August 15, 1997;
revision received October 17, 1997;
accepted November 6, 1997.
2.
Ward OC. A new familial cardiac syndrome in children.
J Ir Med Assoc. 1964;54:103106.[Medline]
[Order article via Infotrieve]
3.
Jervell A, Lange-Nielsen F. Congenital deaf mutism,
functional heart disease with prolongation of the QT interval and
sudden death. Am Heart J. 1957;54:5968.[Medline]
[Order article via Infotrieve]
4.
Wang Q, Curran ME, Splawski I, Burn TC, Millholland
JM, VanRaay TJ, Shen J, Timothy KW, Vincent GM, deJager T, Schwartz PJ,
Towbin JA, Moss AJ, Atkinson DL, Landes GM, Connors TD, Keating MT.
Positional cloning of a novel potassium channel gene: KVLQT1
mutations cause cardiac arrhythmias. Nat Genet. 1996;12:1723.[Medline]
[Order article via Infotrieve]
5.
Curran ME, Splawski I, Timothy KW, Vincent GM, Green
ED, Keating MT. A molecular basis for cardiac arrhythmia:
HERG mutations cause long QT syndrome. Cell. 1995;80:795803.[Medline]
[Order article via Infotrieve]
6.
Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson
JL, Moss AJ, Towbin JA, Keating MT. SCN5A mutations
associated with an inherited cardiac arrhythmia, long QT
syndrome. Cell. 1995;80:805811.[Medline]
[Order article via Infotrieve]
7.
Schott J, Charpentier F, Peltier S, Foley P, Drouin E,
Bouhour J, Donnelly P, Vergnaud G, Bachner L, Moisan J, Marec HL,
Pascal O. Mapping of a gene for long QT syndrome to chromosome
4q25q27. Am J Hum Genet. 1995;57:11141122.[Medline]
[Order article via Infotrieve]
8.
Neyroud N, Tesson F, Denjoy I. A novel mutation in the
potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen
cardioauditory syndrome. Nat Genet. 1997;15:186189.[Medline]
[Order article via Infotrieve]
9.
Splawski I, Timothy K, Vincent GM, Atkinson DL,
Keating MT. Molecular basis of the long QT syndrome associated with
deafness. N Engl J Med. 1997;336:15621567.
10.
Bitner-Glindzicz M, Tyson J, Jamieson R. Molecular
basis of the long QT syndrome. N Engl J Med. 1997;337:10111012.
11.
Barhanin J, Lesage F, Guillemare E, Fink M, Lazdunski
M, Romey G. KvLQT1 and IsK(minK)
proteins associate to form the IKs cardiac
potassium current. Nature. 1996;384:7880.[Medline]
[Order article via Infotrieve]
12.
Sanguinetti MC, Curran ME, Zhou A, Shen J, Spector PS,
Atkinson DL, Keating MT. Coassembly of KvLQT1 and minK(IsK) proteins to
form cardiac IKs potassium channel.
Nature. 1996;384:8083.[Medline]
[Order article via Infotrieve]
13.
McDonald TV, Yu Z, Ming Z, Palma E, Meyers MB, Wang K,
Goldstein SAN, Fishman GI. A minK-HERG complex regulates the cardiac
potassium current IKr.
Nature. 1997;388:289292.[Medline]
[Order article via Infotrieve]
14.
Takumi T, Ohkubo H, Nakanishi S. Cloning of a membrane
protein that induces a slow voltage-gated potassium current.
Science. 1988;242:10421045.
15.
Vetter DE, Mann JR, Wangemann P, Liu J, McLaughlin KJ,
Lesage F, Marcus DC, Lazdunski M, Heinemann SF, Barhanin J. Inner
ear defects induced by null mutation of the Isk gene.
Neuron. 1996;17:12511264.[Medline]
[Order article via Infotrieve]
16.
Friedmann I, Fraser GR, Froggatt P. Pathology of
the ear in the cardioauditory syndrome of Jervell and Lange-Nielsen
(recessive deafness with electrocardiographic abnormalities). J
Laryngol Otol. 1966;80:451470.[Medline]
[Order article via Infotrieve]
17.
Friedmann I, Fraser GR, Froggatt P. Pathology of the
ear in the cardio-auditory syndrome of Jervell and Lange-Nielsen:
report of a third case with an appendix on possible linkage with the Rh
blood group locus. J Laryngol Otol. 1968;82:883896.[Medline]
[Order article via Infotrieve]
18.
Schwartz PJ, Moss AJ, Vincent GM, Crampton RS.
Diagnostic criteria for the long QT syndrome.
Circulation. 1993;88:782784.
19.
Bazett HC. An analysis of the time-relations of
electrocardiograms. Heart. 1920;7:353370.
20.
Tesson F, Donger C, Denjoy I, Berthet M,
Bennaceur M, Petit C, Coumel P, Schwartz K, Guicheney P. Exclusion of
KCNE1(IsK) as a candidate gene for Jervell and Lange-Nielsen Syndrome.
J Mol Cell Cardiol. 1996;28:20512055.[Medline]
[Order article via Infotrieve]
21.
Satler CA, Walsh EP, Vesely MR, Plummer MH, Ginsburg
GS, Jacob HJ. Novel missense mutation in the cyclic
nucleotide-binding domain of HERG causes long QT
syndrome. Am J Med Genet. 1996;65:2735.[Medline]
[Order article via Infotrieve]
22.
Lai L-P, Deng C-L, Moss A, Kass R, Liang C-S.
Polymorphism of the gene encoding a human minimal potassium ion
channel (minK). Gene. 1994;151:339340.[Medline]
[Order article via Infotrieve]
23.
Sanguinetti MC, Jiang C, Curran ME, Keating MT. A
mechanistic link between an inherited and an acquired cardiac
arrhythmia: HERG encodes the
IKr potassium channel. Cell. 1995;81:299307.[Medline]
[Order article via Infotrieve]
24.
Schwartz PJ, Locati EH, Napolitano C, Priori SG. The
long QT syndrome. In: Zipes DP, Jalife J, eds. Cardiac
Electrophysiology: From Cell to Bedside. Philadelphia, Pa: WB
Saunders Co; 1995;1:788811.
25.
Takumi T, Moriyoshi K, Aramori I, Ishii T, Oiki S,
Okada Y, Ohkubo H, Nakanishi S. Alteration of channel activities and
gating by mutations of slow IsK potassium channel. J Biol
Chem. 1991;266:2219222198.
26.
Wang K-W, Goldstein SAN. Subunit composition of MinK
potassium channels. Neuron. 1995;14:13031309.[Medline]
[Order article via Infotrieve]
© 1998 American Heart Association, Inc.
Brief Rapid Communications
Mutation of the Gene for IsK Associated With Both Jervell and Lange-Nielsen and Romano-Ward Forms of Long-QT Syndrome
![]()
Abstract
Top
Abstract
Introduction
Methods
Results
Discussion
Note Added in Proof
References
BackgroundLong-QT syndrome (LQTS)
is a disorder of ventricular repolarization characterized
by a prolonged QT interval, syncope, seizures, and sudden death.
Recently, three forms of LQTS have been shown to result from mutations
in potassium or sodium ion channel genes: KVLQT1 for
LQT1, HERG for LQT2, and SCN5A for LQT3.
IsK, an apparent potassium channel subunit encoded by
KCNE1 on chromosome 21, regulates both KVLQT1 and HERG.
This relationship makes KCNE1 a likely candidate gene,
because mutations of these genes are known to cause both the autosomal
dominant Romano-Ward and recessive Jervell and Lange-Nielsen (JLN)
forms of LQTS.
Key Words: arrhythmia genes molecular biology long-QT syndrome syncope
![]()
Introduction
Top
Abstract
Introduction
Methods
Results
Discussion
Note Added in Proof
References
Long-QT syndrome
(LQTS) is a rare cardiac disorder characterized by abnormal
ventricular repolarization and a prolonged QT interval on
the ECG. Clinically, two inherited forms of LQTS have been defined:
autosomal dominant Romano-Ward syndrome1 2 and
autosomal recessive Jervell and Lange-Nielsen (JLN)
syndrome.3 Patients with both Romano-Ward and JLN
syndrome are predisposed to syncope, seizures, and sudden death,
typically due to polymorphic ventricular
tachycardia (torsade de pointes). In addition, the JLN
syndrome is associated with congenital bilateral deafness, and these
patients often have a more prolonged QTc on
surface ECGs. Romano-Ward syndrome is genetically
heterogeneous, with at least four different known
loci.4 5 6 7 Recently, homozygous mutations of one
of these, KVLQT1, were reported to be responsible for JLN
syndrome in three families.8 9 However, it is
also clear that the disease genes in certain JLN families are not
linked to the KVLQT1 locus.10 Thus,
JLN syndrome must also be a genetically heterogeneous group
of clinically related disorders.
![]()
Methods
Top
Abstract
Introduction
Methods
Results
Discussion
Note Added in Proof
References
Patient Population
Patients with clinical diagnoses of LQTS and their family
members were referred from cardiology clinics in North
America and represented diverse ethnic backgrounds.
Peripheral blood for DNA extraction was collected after
informed consent was obtained according to guidelines approved by the
Children's Hospital Institutional Review Board. Additional data
collected included clinical and family histories of syncope,
palpitations, seizures, hearing loss/deficiency, and sudden cardiac
death, as well as surface ECGs, exercise tests (if available), Holter
studies (if available), and recent clinical notes from the referring
physicians. All probands met established criteria for
LQTS.18 Rate-corrected QT intervals were
calculated by Bazett's formula, where QTc=QT/

and have units of
seconds1/2.19
The proband (LQTS086001) is an 81/2-year-old girl who
presented to the emergency room at age 31/2 years after
a syncopal spell while sliding into a pool. Syncope was preceded by a
gasp and followed by near drowning after she lost consciousness. She
had a history of recurrent syncopal events beginning at 2 years of age,
including a similar event in the pool and a near-syncopal episode after
tickling and playing hard. The patient was congenitally deaf-mute. ECG
indicated a maximal QTc of 0.66 in leads
V2 and V3 at a heart rate
of 67 bpm. While she was on propranolol, an initial Holter
study revealed rare premature ventricular beats and a
prolonged QT interval. On exercise testing, she achieved a maximal
heart rate of 135 at 7 minutes, with a QTc of
0.54 second.
). At exercise testing, while she was
still on propranolol, her maximal heart rate was only 110
bpm, with no ectopy. Holter recording revealed a single
ventricular couplet and a maximal heart rate of 85 bpm. On
the basis of these findings and her history of recurrent syncopal
attacks despite ß-blockade, it was recommended that the patient
undergo surgery. She underwent a partial left stellate gangliectomy and
dorsal sympathectomy and was discharged 3 days later,
still on propranolol (2.5 mg ·
kg-1 · d-1), with
residual Horner's syndrome. Since surgery, she has generally been
doing well, with QTc values ranging from 0.50 to
0.62, but recently she suffered another syncopal episode that was
preceded by prodromal symptoms, including dizzy spells and a general
feeling of malaise.

View larger version (61K):
[in a new window]
Figure 1. ECG tracing from proband (LQTS086001) at 7 years
of age just before surgery, illustrating prolonged QT intervals and
beat-to-beat variation of T-wave morphology in leads II (above) and
V5 (below).
Genomic DNA was prepared from peripheral blood
lymphocytes with the Puregene DNA Isolation kit (Gentra Systems, Inc).
Initial polymerase chain reaction (PCR) assays used primers 1F, 2R, 3F,
and 4R of Tesson et al.20 To amplify additional
portions of the human KCNE1 gene, primers 5F
(5'-GCGCCTGCAGCAGTGGAACCTT-3') and 6R (5'-TTGAATGGGTCGTTCGAGTG-3')
were designed on the basis of a published full-length cDNA sequence
(Genbank M26685; all base numbers in this report are based on this
sequence) (Fig 2A
). These primers amplify
a product of 268 nucleotides containing 11 bp of 5'
untranslated region and codons 1 to 72. The primer 8R
(5'-TTTAGCCAGTGGTGGGGTT-3') was also designed and paired with
previously published primer 3F
(5'-TACATCCGCTCCAAGAAG-3').20 These primers
amplify a product of 216 nucleotides, including the
final 57 codons (eg, 71 to 129) of KCNE1. The promoter and
other transcriptional control elements are not included in these
assays.

View larger version (35K):
[in a new window]
Figure 2. Identification of KCNE1 mutation in
patients with LQTS. A, Schematic of 436-bp contiguous
KCNE1 coding region, indicating relative locations of
different primers used in this study. Box indicates protein coding
portion of gene; *, location of mutated nucleotide 254. B,
Autoradiograph of SSCP gel containing polymerase chain reaction (PCR)
products of primers 3F and 8R from 14 unrelated patients with LQTS.
Products from patient LQTS08601 are in lane 9. Sequencing of
bands labeled A in lanes 7 and 12 revealed that they reflect the D85N
polymorphism. C, Partial DNA sequence of band B from lane 9, panel
A, and a band C with sequencing primer 8R (ie, reverse complement). The
two sequences differ at a single base (indicated by arrow),
demonstrating a G-to-A transition at position 254 on the
KCNE1 mRNA (Genbank M26685). D, Mismatched primer,
mutation-specific, restriction digestion assay for the G-to-A
transition at base 254 on normal control DNAs (lanes 1 to 8) and the
mother, proband, and half sister of family LQTS086 (lanes 9, 10, and
11, respectively). HinfI digestion was omitted in lane 1
to illustrate full-length PCR products. Wild-type DNAs are digested
at two sites to generate a major 73-bp fragment, whereas mutant DNAs
are cut only once to create a 91-bp fragment.
![]()
Results
Top
Abstract
Introduction
Methods
Results
Discussion
Note Added in Proof
References
To test the hypothesis that IsK may be mutated in
patients with LQTS, we used SSCP analyses to screen
KCNE1 in a panel of affected individuals with Romano-Ward or
JLN syndrome. Initial SSCP analyses using primers 1F/2R
identified two previously reported
polymorphisms20 22 but no apparent
LQTS-associated mutations. To allow inclusion of the translational
start and stop sites, we designed three new primers (5F, 6R, 8R) that,
together with 3F, amplify the entire KCNE1 coding region in
two PCR reactions. With these primers, 75 LQTS patients were scored for
the S38G polymorphism22 ; 40% were homozygous
for glycine, 24% were homozygous for serine, and 36% were
heterozygous for the variation. Similarly, 71 patients were scored for
the D85N polymorphism,20 94% were homozygous
for aspartic acid, and 6% were heterozygous at this site. A third
polymorphism was also identified in this population, a G-to-A
transition at base 112, resulting in a previously unreported silent
change at serine codon 28. Of 75 individuals screened, 95% were
homozygous for guanine-112 and 5% were heterozygous for the
change.
). The patient
has a diagnosis of JLN as described above. The aberrant conformer was
not observed in any of the 84 patients with Romano-Ward syndrome or the
3 other JLN patients. DNA sequence analysis of the aberrant
conformer revealed a G-to-A transition at nucleotide 254
that is predicted to create a nonconservative missense mutation of
aspartic acid to asparagine at codon 76 (D76N) (Fig 2C
). The aspartic
acid at position 76 is close to the putative transmembrane region in
the intracellular carboxyl-terminal domain of
IsK,14 and this residue is
completely conserved in mammalian IsK genes (Fig 3
).

View larger version (21K):
[in a new window]
Figure 3. A, Lineup of IsK amino acid
sequences showing high degree of evolutionary conservation in region
around D76. Residue numbers (above) are based on rabbit and rat
sequences, which contain one additional amino acid, at position 30,
relative to other genes. Approximate intracellular boundary of
transmembrane domain is indicated above, as is location of D76N
mutation identified in family LQTS086. B, Predicted molecular topology
of IsK protein illustrating location of D76N mutation in
intracellular domain. Amino (NH3) and carboxyl (COOH) terminal ends of
peptide are indicated, as are two potential N-linked glycosylation
sites (CHO).
). The proband was homozygous for the change, whereas her mother and
half sister were both heterozygous for this mutation. Additional family
members were not available for study.
![]()
Discussion
Top
Abstract
Introduction
Methods
Results
Discussion
Note Added in Proof
References
The identification of KVLQT1 and HERG as
major structural subunits of the IKs and
IKr channels established that abnormalities
of these currents were responsible for
LQTS.11 12 23 Therefore, it was logical to
speculate that mutations of IsK, a probable regulatory
subunit that associates with
KvLQT111 12 and
HERG,13 might also be involved in causing
heritable defects in cardiac repolarization. The present data
implicate the KCNE1 gene as a fifth locus for LQTS (LQT5). A
unique missense mutation, D76N, was found in a homozygous patient with
JLN syndrome and was not detected in 104 normal control individuals.
The proband's DNA was also included in screens of the other three
known LQTS genes, KVLQT1,4HERG,5 and
SCN5A,6 and no mutations were
identified (data not shown). The patient's clinical
presentation included congenital deafness, extremely
prolonged QTc intervals, and recurrent syncopal
events that were refractory to ß-blockade, eventually necessitating
surgical intervention. It may be that this relatively severe clinical
picture is related to the fact that IsK most likely
regulates both the IKs and
IKr currents. The proband's mother and
half sister were both heterozygous for the D76N mutation and had
clinical histories that included syncope, seizures, partial hearing
loss, and/or prolonged QTc intervals. These
findings are consistent with previous reports of JLN pedigrees
in which homozygous individuals have severe cardiac disease and
complete hearing loss, whereas obligate heterozygotes may have a milder
phenotype more closely resembling the Romano-Ward form of
LQTS.8 9 24
![]()
Note Added in Proof
Top
Abstract
Introduction
Methods
Results
Discussion
Note Added in Proof
References
KCNE1 mutations in patients with LQTS have also
recently been reported by Schultze-Bahr et al. and Splawski et al.
(Nat Genet. 1997;17:267268 and 338340, respectively).
![]()
Acknowledgments
This study was supported in part by the Boston
Children's Heart Foundation and by grants R01-AR44345 and K02-AR02026
from the NIH. Thanks to the many patients and physicians who have
contributed clinical specimens and data to this project. The
authors also gratefully acknowledge Drs Peter Zimetbaum, Philip Saul,
David Clapham, Edward Walsh, Fumio Takada, and Louis Kunkel for
critical advice and helpful comments on this work.
![]()
Footnotes
Presented in part at the 70th Scientific Sessions of the American Heart Association, Orlando, Fla, November 1013, 1997, and published in abstract form (Circulation. 1997;96[suppl I]:I-56).
![]()
References
Top
Abstract
Introduction
Methods
Results
Discussion
Note Added in Proof
References
1.
Romano C, Gemme G, Pongiglione R. Aritmie
cardiache rare dell'eta pediatrica, II: accessi sincopali per
firrillazione ventricolare parossistica. Clin Pediatr
(Bologna). 1963;45:656683.[Medline]
[Order article via Infotrieve]
This article has been cited by other articles:
![]() |
Z. Gao, Q. Xiong, H. Sun, and M. Li Desensitization of Chemical Activation by Auxiliary Subunits: CONVERGENCE OF MOLECULAR DETERMINANTS CRITICAL FOR AUGMENTING KCNQ1 POTASSIUM CHANNELS J. Biol. Chem., August 15, 2008; 283(33): 22649 - 22658. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Park and F. Sesti An Arrhythmia Susceptibility Gene in Caenorhabditis elegans J. Biol. Chem., July 6, 2007; 282(27): 19799 - 19807. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Thomas, M. J. Killeen, I. S. Gurung, P. Hakim, R. Balasubramaniam, C. A. Goddard, A. A. Grace, and C. L.-H. Huang Mechanisms of ventricular arrhythmogenesis in mice following targeted disruption of KCNE1 modelling long QT syndrome 5 J. Physiol., January 1, 2007; 578(1): 99 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, S. Y. Um, and T. V. Mcdonald Voltage-Gated Potassium Channels: Regulation by Accessory Subunits Neuroscientist, June 1, 2006; 12(3): 199 - 210. [Abstract] [PDF] |
||||
![]() |
A. Krumerman, X. Gao, J.-S. Bian, Y. F. Melman, A. Kagan, and T. V. McDonald An LQT mutant minK alters KvLQT1 trafficking Am J Physiol Cell Physiol, June 1, 2004; 286(6): C1453 - C1463. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Balasubramaniam, A. A Grace, R. C Saumarez, J. I Vandenberg, and C. L-H Huang Electrogram prolongation and nifedipine-suppressible ventricular arrhythmias in mice following targeted disruption of KCNE1 J. Physiol., October 15, 2003; 552(2): 535 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yong, X. Tian, and Q. Wang LQT4 Gene: The "Missing" Ankyrin Mol. Interv., May 1, 2003; 3(3): 131 - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Anantharam, A. Lewis, G. Panaghie, E. Gordon, Z. A. McCrossan, D. J. Lerner, and G. W. Abbott RNA Interference Reveals That Endogenous Xenopus MinK-related Peptides Govern Mammalian K+ Channel Function in Oocyte Expression Studies J. Biol. Chem., March 28, 2003; 278(14): 11739 - 11745. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Grunnet, T. Jespersen, H. B. Rasmussen, T. Ljungstrom, N. K Jorgensen, S.-P. Olesen, and D. A Klaerke KCNE4 is an inhibitory subunit to the KCNQ1 channel J. Physiol., July 1, 2002; 542(1): 119 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. ABBOTT and S. A. N. GOLDSTEIN Disease-associated mutations in KCNE potassium channel subunits (MiRPs) reveal promiscuous disruption of multiple currents and conservation of mechanism FASEB J, March 1, 2002; 16(3): 390 - 400. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Huang, M. Bitner-Glindzicz, L. Tranebjaerg, and A. Tinker A spectrum of functional effects for disease causing mutations in the Jervell and Lange-Nielsen syndrome Cardiovasc Res, September 1, 2001; 51(4): 670 - 680. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Abbott and S. A. N. Goldstein Potassium Channel Subunits: The MiRP Family Mol. Interv., June 1, 2001; 1(2): 95 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Benatar Neurological potassium channelopathies QJM, December 1, 2000; 93(12): 787 - 797. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Shieh, M. Coghlan, J. P. Sullivan, and M. Gopalakrishnan Potassium Channels: Molecular Defects, Diseases, and Therapeutic Opportunities Pharmacol. Rev., December 1, 2000; 52(4): 557 - 594. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bianchi, S. G. Priori, C. Napolitano, K. A. Surewicz, A. T. Dennis, M. Memmi, P. J. Schwartz, and A. M. Brown Mechanisms of IKs suppression in LQT1 mutants Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H3003 - H3011. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Splawski, J. Shen, K. W. Timothy, M. H. Lehmann, S. Priori, J. L. Robinson, A. J. Moss, P. J. Schwartz, J. A. Towbin, G. M. Vincent, et al. Spectrum of Mutations in Long-QT Syndrome Genes : KVLQT1, HERG, SCN5A, KCNE1, and KCNE2 Circulation, September 5, 2000; 102(10): 1178 - 1185. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. C.-H. Yang, M. W. Scherz, A. Bahinski, P. B. Bennett, and K. T. Murray Stereoselective Interactions of the Enantiomers of Chromanol 293B with Human Voltage-Gated Potassium Channels J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 955 - 962. [Abstract] [Full Text] |
||||
![]() |
C.-E. Chiang and D. M. Roden The long QT syndromes: genetic basis and clinical implications J. Am. Coll. Cardiol., July 1, 2000; 36(1): 1 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chouabe, N. Neyroud, P. Richard, I. Denjoy, B. Hainque, G. Romey, M.-D. Drici, P. Guicheney, and J. Barhanin Novel mutations in KvLQT1 that affect Iks activation through interactions with Isk Cardiovasc Res, March 1, 2000; 45(4): 971 - 980. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Lehmann-Horn and K. Jurkat-Rott Voltage-Gated Ion Channels and Hereditary Disease Physiol Rev, October 1, 1999; 79(4): 1317 - 1372. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Viswanathan, R. M. Shaw, and Y. Rudy Effects of IKr and IKs Heterogeneity on Action Potential Duration and Its Rate Dependence : A Simulation Study Circulation, May 11, 1999; 99(18): 2466 - 2474. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Salinas, R. Reyes, F. Lesage, M. Fosset, C. Heurteaux, G. Romey, and M. Lazdunski Cloning of a New Mouse Two-P Domain Channel Subunit and a Human Homologue with a Unique Pore Structure J. Biol. Chem., April 23, 1999; 274(17): 11751 - 11760. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Babij, G. R. Askew, B. Nieuwenhuijsen, C.-M. Su, T. R. Bridal, B. Jow, T. M. Argentieri, J. Kulik, L. J. DeGennaro, W. Spinelli, et al. Inhibition of Cardiac Delayed Rectifier K+ Current by Overexpression of the Long-QT Syndrome HERG G628S Mutation in Transgenic Mice Circ. Res., September 21, 1998; 83(6): 668 - 678. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-D. Drici, I. Arrighi, C. Chouabe, J. R. Mann, M. Lazdunski, G. Romey, and J. Barhanin Involvement of IsK-Associated K+ Channel in Heart Rate Control of Repolarization in a Murine Engineered Model of Jervell and Lange-Nielsen Syndrome Circ. Res., July 13, 1998; 83(1): 95 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. F. Melman, A. Domenech, S. de la Luna, and T. V. McDonald Structural Determinants of KvLQT1 Control by the KCNE Family of Proteins J. Biol. Chem., February 23, 2001; 276(9): 6439 - 6444. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |